Day One to Participate in the Piper Sandler 36th Annual Healthcare Conference

Rhea-AI Summary

Day One Biopharmaceuticals (Nasdaq: DAWN) has announced its participation in the Piper Sandler 36th Annual Healthcare Conference. The company's management will engage in a fireside chat on Tuesday, December 3 at 3:00 p.m. EST.

Interested parties can access a live webcast of the discussion through the Events & Presentations section of Day One's Investors & Media page. The webcast recording will remain available for 30 days after the live event.

BRISBANE, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced that management will participate in a fireside chat at the Piper Sandler 36^th Annual Healthcare Conference on Tuesday, December 3 at 3:00 p.m. EST.

A live webcast of the discussion will be available by visiting the Events & Presentations section of the Day One Investors & Media page. An archived replay of the webcast will be available for 30 days following the live event.

About Day One Biopharmaceuticals
Day One Biopharmaceuticals believes when it comes to pediatric cancer, we can do better. The Company was founded to address a critical unmet need: the dire lack of therapeutic development in pediatric cancer. Inspired by “The Day One Talk” that physicians have with patients and their families about an initial cancer diagnosis and treatment plan, Day One aims to re-envision cancer drug development and redefine what’s possible for all people living with cancer—regardless of age—starting from Day One.

Day One partners with leading clinical oncologists, families, and scientists to identify, acquire, and develop important targeted cancer treatments. The Company’s pipeline includes tovorafenib (OJEMDA™), DAY301 and a VRK1 inhibitor program.

Day One is based in Brisbane, California. For more information, please visit www.dayonebio.com or find the Company on LinkedIn or X.

Day One uses its Investor Relations website (ir.dayonebio.com), its X handle (x.com/DayOneBio), and LinkedIn Home Page (linkedin.com/company/dayonebio) as a means of disseminating or providing notification of, among other things, news or announcements regarding its business or financial performance, investor events, press releases, and earnings releases, and as a means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation FD.

DAY ONE MEDIA
Laura Cooper, Head of Communications
media@dayonebio.com

DAY ONE INVESTORS
LifeSci Advisors, PJ Kelleher
pkelleher@lifesciadvisors.com

FAQ

When is Day One Biopharmaceuticals (DAWN) presenting at the Piper Sandler Healthcare Conference?

Day One Biopharmaceuticals (DAWN) will present at the Piper Sandler Healthcare Conference on Tuesday, December 3 at 3:00 p.m. EST.

How can I watch Day One Biopharmaceuticals' (DAWN) presentation at the Piper Sandler Conference?

You can watch the presentation through a live webcast available in the Events & Presentations section of Day One's Investors & Media page.

How long will Day One Biopharmaceuticals' (DAWN) Piper Sandler Conference webcast be available?

The webcast recording will be available for 30 days following the live event.

What type of presentation will Day One Biopharmaceuticals (DAWN) give at the Piper Sandler Conference?

Day One Biopharmaceuticals will participate in a fireside chat format presentation at the conference.